Daehwa Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daehwa Pharmaceutical Company Limited with three other
companies in this sector in KOREA (SOUTH) :
Korea Arlico Pharm Co Ltd
sales of 115.79 billion Korean Won [US$94.72 million]
of which 100%
was Medical Supplies Manufacturing Segment),
HLB Life Science Co Ltd
(114.02 billion Korean Won [US$93.27 million]
of which 95%
was Distribution Industry), and
Kukje Pharma Co Ltd
(111.12 billion Korean Won [US$90.90 million]
of which 95%
Daehwa Pharmaceutical Company Limited reported sales of 114.61 billion Korean Won (US$93.75 million)
December of 2019.
increase of 4.1%
versus 2018, when the company's sales were 110.14 billion Korean Won .
Despite this increase, sales are still
below the level achieved in 2017, when Daehwa Pharmaceutical Company Limited
reported sales of 122.20 billion Korean Won .
Sales of Medicine Mafufacture saw an increase
that was more than double the company's growth rate: sales were up
9.3% in 2019, from
80.23 billion Korean Won to 87.66 billion Korean Won .
Not all segments of Daehwa Pharmaceutical Company Limited experienced an increase in sales in 2019:
sales of Medical Information System fell 34.3% to 241.12 million Korean Won .
(However, this segment's sales were only a very small portion of the company's overall sales).
Daehwa Pharmaceutical Company Limited also experienced decreases in sales in
Medicine Sales (down 4.1% to 18.89 billion Korean Won )
Manufacturing and Sale of Cosmetics and Me (down 13.7% to 5.34 billion Korean Won )
Medicine Material Manufacturing (down 32.3% to 2.48 billion Korean Won )